2 results
Approved WMORecruiting
To compare the efficacy of six cycles neoadjuvant PTC plus pertuzumab preceded by either three cycles of FEC-T plus pertuzumab or three cycles of PTC plus pertuzumab in HER2 positive breast cancerSecondary objectives• To describe the safety of the…
Approved WMORecruiting
The purpose of this study is to develop a new investigational procedure for diagnosing Barrett*s Esophagus (BE) and Esophageal Adenocarcinoma (EAC).